drug: lithium
- Clinical class: antimanic, mood stabilizer
- Chemical class: metal, mineral salt
- Active metabolite: none
- CSA schedule: none
- DEA number: none
- MEDLINEplus® Drug Information
U.S. Preparations:
- Eskalith®, Eskalith CR® (GlaxoSmithKline) FDA approved for treatment of: manic episodes and prophylaxis of bipolar disorder WARNING
- Lithobid®, Lithonate® (discontinued 1.1.99), Lithotabs® (discontinued 1.1.99): (Solvay) FDA approved for treatment of: manic episodes and prophylaxis of bipolar disorder WARNING
Preparations Outside U.S.:
- Camcolit, Carbolith, Carbolithium, Contemnol, Duralith, Hypnorex, Lentolith, Leukominerase, Liskonum, Litarex, Lithane, Lithicarb, Lithiofor, Lithionit, Lithiumkarbonat, Lithiumorotat, Lithizine, Lito, Litoduron, Maniprex, Milithin, Neurolepsin, Neurolithium, Phasal, Plenur, Priadel, Quilonum, Quilonorm, Teralithe
| Books and Other Media: Follow the hypertext link to purchase items online. |
|
- John Bohn M.D., James W. Jefferson M.D. Lithium and Manic Depression- A Guide (Paperback - June 1996)
- El-Mallakh, MD, Rif S. Lithium : Actions and Mechanisms (Progress in Psychiatry Series, No 50) Hardcover 1996 -"This book critically reviews major mechanistic theories of lithium actions and combines basic mechanisms with clinical application."
- Jefferson, James W, Greist, John H., & Ackerman, Deborah L. Lithium Encyclopedia for Clinical Practice
- Schou, Mogens Lithium Treatment of Manic Depressive Illness - A Practical Guide Paperback 1992